REVIVA Trademark

Trademark Overview

On Thursday, April 26, 2007, a trademark application was filed for REVIVA with the United States Patent and Trademark Office. The USPTO has given the REVIVA trademark a serial number of 77166973. The federal status of this trademark filing is REGISTERED AND RENEWED as of Wednesday, November 24, 2021. This trademark is owned by Reviva Pharmaceuticals, Inc.. The REVIVA trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Pharmaceutical drug research and development, including conducting clinical trials and consulting services related thereto; pharmaceutical research and development services, namely, designing, conducting and managing clinical trials and reporting the results of same; providing analysis and design services in the field of drug development and conducting clinical trials of newly developed drugs
reviva

General Information

Serial Number77166973
Word MarkREVIVA
Filing DateThursday, April 26, 2007
Status800 - REGISTERED AND RENEWED
Status DateWednesday, November 24, 2021
Registration Number4016184
Registration DateTuesday, August 23, 2011
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 8, 2008

Trademark Statements

Goods and ServicesPharmaceutical drug research and development, including conducting clinical trials and consulting services related thereto; pharmaceutical research and development services, namely, designing, conducting and managing clinical trials and reporting the results of same; providing analysis and design services in the field of drug development and conducting clinical trials of newly developed drugs

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, May 1, 2007
Primary Code042
First Use Anywhere DateTuesday, November 30, 2010
First Use In Commerce DateTuesday, November 30, 2010

Trademark Owner History

Party NameReviva Pharmaceuticals, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressCupertino, CA 95014
Party NameReviva Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSan Jose, CA 95138
Party NameReviva Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Jose, CA 95138

Trademark Events

Event DateEvent Description
Wednesday, November 24, 2021NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Wednesday, November 24, 2021REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Wednesday, November 24, 2021REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Wednesday, November 24, 2021CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Thursday, July 1, 2021TEAS SECTION 8 & 9 RECEIVED
Sunday, August 23, 2020COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Wednesday, September 27, 2017NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Wednesday, September 27, 2017REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Tuesday, September 26, 2017CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Tuesday, August 22, 2017TEAS SECTION 8 & 15 RECEIVED
Tuesday, August 23, 2011REGISTERED-PRINCIPAL REGISTER
Wednesday, July 20, 2011NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, July 19, 2011LAW OFFICE REGISTRATION REVIEW COMPLETED
Monday, July 18, 2011ASSIGNED TO LIE
Sunday, July 17, 2011ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Thursday, July 7, 2011ASSIGNED TO EXAMINER
Wednesday, July 6, 2011STATEMENT OF USE PROCESSING COMPLETE
Tuesday, June 28, 2011USE AMENDMENT FILED
Tuesday, June 28, 2011TEAS STATEMENT OF USE RECEIVED
Friday, January 7, 2011NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, January 6, 2011EXTENSION 5 GRANTED
Saturday, January 1, 2011EXTENSION 5 FILED
Monday, January 3, 2011TEAS EXTENSION RECEIVED
Wednesday, October 13, 2010ASSIGNED TO EXAMINER
Thursday, July 29, 2010NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, July 28, 2010EXTENSION 4 GRANTED
Thursday, July 1, 2010EXTENSION 4 FILED
Thursday, July 8, 2010EXTENSION RECEIVED WITH TEAS PETITION
Thursday, July 8, 2010PETITION TO REVIVE-GRANTED
Thursday, July 8, 2010TEAS PETITION TO REVIVE RECEIVED
Thursday, January 7, 2010EXTENSION 3 GRANTED
Friday, January 1, 2010EXTENSION 3 FILED
Monday, January 4, 2010TEAS EXTENSION RECEIVED
Wednesday, July 22, 2009EXTENSION 2 GRANTED
Monday, June 29, 2009EXTENSION 2 FILED
Wednesday, July 22, 2009CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, June 29, 2009TEAS EXTENSION RECEIVED
Tuesday, December 30, 2008EXTENSION 1 GRANTED
Tuesday, December 30, 2008EXTENSION 1 FILED
Tuesday, December 30, 2008TEAS EXTENSION RECEIVED
Tuesday, July 1, 2008NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, April 8, 2008PUBLISHED FOR OPPOSITION
Wednesday, March 19, 2008NOTICE OF PUBLICATION
Thursday, March 6, 2008LAW OFFICE PUBLICATION REVIEW COMPLETED
Monday, March 3, 2008ASSIGNED TO LIE
Thursday, February 7, 2008APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, February 7, 2008EXAMINER'S AMENDMENT ENTERED
Thursday, February 7, 2008NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, February 7, 2008EXAMINERS AMENDMENT E-MAILED
Thursday, February 7, 2008EXAMINERS AMENDMENT -WRITTEN
Thursday, August 9, 2007NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, August 9, 2007NON-FINAL ACTION E-MAILED
Thursday, August 9, 2007NON-FINAL ACTION WRITTEN
Thursday, August 9, 2007ASSIGNED TO EXAMINER
Tuesday, May 1, 2007NEW APPLICATION ENTERED IN TRAM

Related Keywords

reviva clinical services conducting trials development pharmaceutical drug research design providing